Beam Therapeutics (BEAM) announced the appointment of Sravan Emany as CFO, effective December 19, 2024. He most recently served as CFO and COO at Ironwood Pharmaceuticals (IRWD)
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics Strengthens Board with Pharma Veteran
- Beam Therapeutics appoints Guindo to its board of directors
- Beam Therapeutics management to meet virtually with Cantor Fitzgerald
- Beam Therapeutics participates in a conference call with JPMorgan
- Beam Therapeutics upgraded to Outperform from Market Perform at Leerink